Clinical trials: Acute Copd Exacerbation
COPD Exacerbation
Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)
The primary aim is to determine whether nebulized Formoterol twice daily plus Revefenacin once daily is non-inferior to standard-of-care nebulized Albuterol and Ipratropium therapy four times daily in relieving dyspnea among…
- Trial name
- NCT07721922
- Testing
- Revefenacin, formoterol fumarate, Albuterol sulfate
- Where
- United States
- Volunteers
- 280 people
- Sponsor
- University of Tennessee Graduate School of Medicine
COPD, Physical Activity
Transcutaneous Electrical Nerve Stimulation During Exercise in Patients With COPD
Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training.
- Conditions
- COPD, Physical Activity, Rehabilitation, TEN
- Trial name
- proTENS (NCT03548870)
- Testing
- CWRT with low frequency transcutaneous electrical nerve stimulation
- Where
- France
- Volunteers
- 2 people
- Sponsor
- Groupe Hospitalier du Havre
COPD
Real Time Early Warning Model and Mobile Medical Assistant System for the Impact of Air Pollution on AECOPD Disease
Objective to establish a real-time early warning model of acute exacerbation of chronic obstructive pulmonary disease (COPD) caused by air pollution, and develop the corresponding mobile medical assistant system.
- Trial name
- NCT04960410
- Testing
- Types and exposure of different air pollutants
- Volunteers
- 56 people
- Sponsor
- Peking University Third Hospital
Lower Respiratory Tract Infection (LRTI)
Procalcitonin Antibiotic Consensus Trial (ProACT)
The ProACT study is a 5 year, multicenter study that will test the effect of implementation of a novel procalcitonin guideline on antibiotic use and adverse outcomes in Emergency Department (ED) patients with Lower Respiratory…
- Trial name
- ProACT (NCT02130986)
- Testing
- Procalcitonin level, Results of procalcitonin (PCT) level to treating clinician, Provide procalcitonin guideline to treating clinician
- Where
- 13 sites in United States
- Volunteers
- 1,664 people
- Sponsor
- University of Pittsburgh
COPD Exacerbation
NIV - NAVA vs NIV - PS for COPD Exacerbation
Number of Patients: Total no. of patients = 40 patients NIV-PSV group (Group A) = 20 NIV-NAVA group (Group B) = 20 Inclusion criteria a) Patients of Chronic obstructive pulmonary disease with acute hypercapnic respiratory failure…
- Trial name
- NAVA-NICE (NCT02912689)
- Testing
- Neurally Adjusted Ventilator Assist, Pressure support ventilation
- Where
- India
- Volunteers
- 40 people
- Sponsor
- All India Institute of Medical Sciences